← Evidence map

ReviewAntibody therapeutics2026

Bispecific and multispecific T-cell engagers: advancing the future of immunotherapy.

Xiaoqiang Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41561192